Health
Biotechnology
Biopharmaceutical

Incyte

$79.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.51 (-1.86%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours

Why Robinhood?

You can buy or sell Incyte and other stocks, options, ETFs, and crypto commission-free!

About INCY

CEO
Employees
1,367
Headquarters
Founded
1991
Market Cap
17.12B
Price-Earnings Ratio
68.26
Dividend Yield
0.00
Average Volume
1.44M
High Today
$81.49
Low Today
$79.70
Open Price
$81.39
Volume
814.12K
52 Week High
$89.30
52 Week Low
$57.00

Collections

Health
Biotechnology
Biopharmaceutical
Pharmaceutical
Technology
Therapy

INCY News

MarketWatchJul 2

Incyte enters license pact with Zai Lab to commercialize its cancer treatment in Greater China

179
Yahoo FinanceJun 20

The Zacks Analyst Blog Highlights: Incyte, Blueprint Medicines, Verastem and uniQure

106
Yahoo FinanceJun 18

See what the IHS Markit Score report has to say about Incyte Corp.

21

INCY Earnings

-$0.43
-$0.08
$0.27
$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 30, Pre-Market

More INCY News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.